Brief: WUYI PHARMA discloseable transaction acquisition of sale shares (involving the issue of consideration shares under general mandate)
Dec 9 (Reuters) - Wuyi International Pharmaceutical Co Ltd 1889.HK : * Discloseable transaction acquisition of sale shares (involving the issue of consideration shares under general mandate) 1889.HK * Purchaser (an indirect wholly-owned subsidiary of the company), the target company and the vendors entered into the share transfer agreement * Says total consideration of hk$145 million * Purchaser shall not be obliged to acquire the sale shares unless the sale shares are sold by vendors simultaneously Source text for Eikon ID:nHKS3L7ZRC ((For more news, please click here 1889.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Sanai Health Industry
See all newsBrief: Sanai Health Industry Says She Hao Resigned As Executive Director And Deputy CEO
Brief: Sanai Health Industry Gets Final Judgement Regarding Second Appeal From High People's Court Of Beijing
Brief: Sanai Health Industry Group Co Expects Loss Of RMB25.5 Million-RMB27.5 Million For Year
Brief: Sanai Health Industry's Unit To Sell 99% Equity Interest In Luannan Hangyang Health Industry
Brief: Sanai Health Industry Expects HY Loss Attributable Of RMB11.5 Million And RMB14.0 Million